Philanthropy & Grantmaking
(T22)
IRS Verified
DX Registered
990 on File
CURE MITO FOUNDATION
Financial strength (30%)
78/100
Reliability (20%)
69/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
21
CharityAI™ Score
out of 100
Mission Statement
The Cure Mito Foundation is a leading patient advocacy organization dedicated to Leigh syndrome and mitochondrial diseases research and empowering affected families worldwide. We provide opportunities to connect, learn, and find resources, strength, and courage to live your best life. We are proud members of the Rare As One Network, supported by a grant from the Chan Zuckerberg Initiative (CZI).
Financial Overview — FY 2025
$479K
Total Revenue
$502K
Total Expenses
$1.1M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
79.0%
Fundraising Efficiency
N/A
Operating Reserve
25.17x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Executive Compensation
$61K
Compared with Peers
FY 2025
Compared with 8,005 similar organizations
(United States, Philanthropy & Grantmaking, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
79.0% | 90.0% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
21.0% | 7.6% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
25.2 mo | 98.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 90.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-29.0% | 11.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
50.1% | 8.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-5.0% | 4.5% |
P10P90
|
CharityAI™ Evaluation — 2025
21 / 1000
Financial
49
Reliability
33
Effectiveness
10
Impact
Financial Strength (30%)
0
Reliability & Transparency (20%)
49
Program Effectiveness (25%)
33
Impact & Outcomes (25%)
10
0 programs
IRS Verified 80% Data Complete
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $479K | $502K | $1.1M | 79.0% | 2 |
| 2024 | $674K | $335K | $1.1M | 97.4% | 0 |
| 2023 | $560K | $201K | $750K | 100.0% | 0 |
| 2022 | $481K | $216K | $392K | 86.7% | 0 |
| 2021 | $99K | $52K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.